Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

489 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Childhood meningitis in the conjugate vaccine era: a prospective cohort study.
Sadarangani M, Willis L, Kadambari S, Gormley S, Young Z, Beckley R, Gantlett K, Orf K, Blakey S, Martin NG, Kelly DF, Heath PT, Nadel S, Pollard AJ. Sadarangani M, et al. Among authors: kelly df. Arch Dis Child. 2015 Mar;100(3):292-4. doi: 10.1136/archdischild-2014-306813. Epub 2014 Sep 25. Arch Dis Child. 2015. PMID: 25256088
Haemophilus influenzae type b conjugate vaccines.
Kelly DF, Moxon ER, Pollard AJ. Kelly DF, et al. Immunology. 2004 Oct;113(2):163-74. doi: 10.1111/j.1365-2567.2004.01971.x. Immunology. 2004. PMID: 15379976 Free PMC article. Review.
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunization.
Snape MD, Kelly DF, Salt P, Green S, Snowden C, Diggle L, Borkowski A, Yu LM, Moxon ER, Pollard AJ. Snape MD, et al. Among authors: kelly df. Clin Infect Dis. 2006 Dec 1;43(11):1387-94. doi: 10.1086/508776. Epub 2006 Oct 31. Clin Infect Dis. 2006. PMID: 17083009 Clinical Trial.
The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response.
Blanchard Rohner G, Snape MD, Kelly DF, John T, Morant A, Yu LM, Borkowski A, Ceddia F, Borrow R, Siegrist CA, Pollard AJ. Blanchard Rohner G, et al. Among authors: kelly df. J Immunol. 2008 Feb 15;180(4):2165-73. doi: 10.4049/jimmunol.180.4.2165. J Immunol. 2008. PMID: 18250423
489 results